BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21040473)

  • 41. Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma.
    Todenhöfer T; Gibb EA; Seiler R; Kamyabi A; Hennenlotter J; McDonald P; Moskalev I; Stewart C; Gao J; Fazli L; Dedhar S; Stenzl A; Oo HZ; Black PC
    Urol Oncol; 2021 Aug; 39(8):498.e1-498.e11. PubMed ID: 34083096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy.
    Koukourakis MI; Giatromanolaki A; Danielidis V; Sivridis E
    Int J Radiat Biol; 2008 Jan; 84(1):47-52. PubMed ID: 17852557
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of carbonic anhydrase 9 in regulating extracellular and intracellular ph in three-dimensional tumor cell growths.
    Swietach P; Patiar S; Supuran CT; Harris AL; Vaughan-Jones RD
    J Biol Chem; 2009 Jul; 284(30):20299-310. PubMed ID: 19458084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbonic anhydrase 9 (CA9) expression in tumor cells enhances sensitivity to tirapazamine.
    Shin HJ; Kim JY; Yoo CW; Roberts SA; Lee S; Choi SJ; Lee HY; Lee DH; Kim TH; Cho KH
    J Cancer Res Clin Oncol; 2008 Mar; 134(3):397-404. PubMed ID: 17724612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Induction of drug resistance in Tca8113 cell line by exposing to chemotherapy drug].
    Feng G; Wang DZ; Chen HQ; He J; Leng W
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2007 Apr; 25(2):184-7. PubMed ID: 17663348
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dickkopf-1 (DKK-1) interrupts FAK/PI3K/mTOR pathway by interaction of carbonic anhydrase IX (CA9) in tumorigenesis.
    Kim BR; Shin HJ; Kim JY; Byun HJ; Lee JH; Sung YK; Rho SB
    Cell Signal; 2012 Jul; 24(7):1406-13. PubMed ID: 22430125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs.
    Tanabe K; Kim R; Inoue H; Emi M; Uchida Y; Toge T
    Int J Oncol; 2003 Apr; 22(4):875-81. PubMed ID: 12632082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
    Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
    J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytotoxic effect of pingyangmycin on cultured KB cells.
    Tai KW; Chang YC; Chou LS; Chou MY
    Oral Oncol; 1998 May; 34(3):219-23. PubMed ID: 9692057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer.
    Simi L; Venturini G; Malentacchi F; Gelmini S; Andreani M; Janni A; Pastorekova S; Supuran CT; Pazzagli M; Orlando C
    Lung Cancer; 2006 Apr; 52(1):59-66. PubMed ID: 16513206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of aryl hydrocarbon receptor in modulation of the expression of the hypoxia marker carbonic anhydrase IX.
    Takacova M; Holotnakova T; Vondracek J; Machala M; Pencikova K; Gradin K; Poellinger L; Pastorek J; Pastorekova S; Kopacek J
    Biochem J; 2009 Apr; 419(2):419-25. PubMed ID: 19154183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of antibody-targeted chemotherapy with pingyangmycin on prostate cancer cells in vitro].
    Chen WZ; Zhang Y; Liang CS; Xie Y; Wen QQ; Gao X
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):406-8. PubMed ID: 18359702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Reversal effect of hyperthemia on multidrug resistant phenomena].
    Zhang P; Wang D; Zheng G
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Apr; 21(2):127-9. PubMed ID: 12838699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antitumor effect of the novel immunoconjugate composed of pingyangmycin and anti-type IV collagenase monoclonal antibody].
    Dai Y; Liu XJ; Zhen YS
    Yao Xue Xue Bao; 2006 Jan; 41(1):41-6. PubMed ID: 16683526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer.
    Lee S; Toft NJ; Axelsen TV; Espejo MS; Pedersen TM; Mele M; Pedersen HL; Balling E; Johansen T; Burton M; Thomassen M; Vahl P; Christiansen P; Boedtkjer E
    Breast Cancer Res; 2023 Apr; 25(1):46. PubMed ID: 37098526
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extracellular acidosis elevates carbonic anhydrase IX in human glioblastoma cells via transcriptional modulation that does not depend on hypoxia.
    Ihnatko R; Kubes M; Takacova M; Sedlakova O; Sedlak J; Pastorek J; Kopacek J; Pastorekova S
    Int J Oncol; 2006 Oct; 29(4):1025-33. PubMed ID: 16964400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral cancer-associated fibroblasts inhibit heat-induced apoptosis in Tca8113 cells through upregulated expression of Bcl-2 through the Mig/CXCR3 axis.
    Bian L; Sun X; Jin K; He Y
    Oncol Rep; 2012 Dec; 28(6):2063-8. PubMed ID: 22961626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
    Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA
    Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-associated carbonic anhydrase 9 spatially coordinates intracellular pH in three-dimensional multicellular growths.
    Swietach P; Wigfield S; Cobden P; Supuran CT; Harris AL; Vaughan-Jones RD
    J Biol Chem; 2008 Jul; 283(29):20473-83. PubMed ID: 18482982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of carbonic anhydrase 9-expressing tumor cells in the lymph nodes of vulvar carcinoma patients by RT-PCR.
    Kowalewska M; Radziszewski J; Kulik J; Barathova M; Nasierowska-Guttmajer A; Bidziński M; Pastorek J; Pastorekova S; Siedlecki JA
    Int J Cancer; 2005 Oct; 116(6):957-62. PubMed ID: 15856466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.